Cash, Cash Equivalents, Marketable Securities, and Restricted Cash (Tables)

3 Months Ended

Mar. 31, 2023

Cash, Cash Equivalents, and Short-Term Investments [Abstract]

Schedule of Cash, Cash Equivalents and Marketable Securities

Cash, cash equivalents and marketable securities are classified as current unless mentioned otherwise below and consisted of the following:


	As of March 31, 2023
(in thousands)	Cost		Gross Unrealized Gain		Gross Unrealized Loss		Fair Value
Cash and cash equivalents	$	160,602	$	—	$	—	$	160,602
Commercial paper	106,109		14		(17)		106,106
Money market	350		—		—		350
Certificates of deposit	51		—		—		51
	$	267,112	$	14	$	(17)	$	267,109
Included in cash and cash equivalents	$	160,602	$	—	$	—	$	160,602
Included in marketable securities	106,510		14		(17)		106,507
Total cash, cash equivalents, and marketable securities	$	267,112	$	14	$	(17)	$	267,109


	As of December 31, 2022
(in thousands)	Cost		Gross Unrealized Gain		Gross Unrealized Loss		Fair Value
Cash and cash equivalents	$	148,813	$	—	$	—	$	148,813
Commercial paper	144,299		82		—		144,381
Money market	350		—		—		350
Certificate of deposit	51		—		—		51
	$	293,513	$	82	$	—	$	293,595
Included in cash and cash equivalents	$	148,813	$	—	$	—	$	148,813
Included in marketable securities	144,700		82		—		144,782
Total cash, cash equivalents, and marketable securities	$	293,513	$	82	$	—	$	293,595

Schedule of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Company's Consolidated Balance Sheets that sum to the total of the same such amounts shown in the Company's Consolidated Statements of Cash Flows.


	As of March 31,
(in thousands)	2023		2022
Cash and cash equivalents	$	160,602	$	233,317
Restricted cash	4,381		4,506
Cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows	$	164,983	$	237,823